These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20402794)

  • 1. Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes.
    De Bernardis F; Santoni G; Boccanera M; Lucciarini R; Arancia S; Sandini S; Amantini C; Cassone A
    FEMS Yeast Res; 2010 Jun; 10(4):432-40. PubMed ID: 20402794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
    Sandini S; La Valle R; Deaglio S; Malavasi F; Cassone A; De Bernardis F
    FEMS Immunol Med Microbiol; 2011 Jul; 62(2):215-24. PubMed ID: 21535228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.
    De Bernardis F; Lucciarini R; Boccanera M; Amantini C; Arancia S; Morrone S; Mosca M; Cassone A; Santoni G
    Infect Immun; 2006 Jul; 74(7):4282-94. PubMed ID: 16790803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 1 T helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasis.
    Piccinni MP; Vultaggio A; Scaletti C; Livi C; Gomez MJ; Giudizi MG; Biagiotti R; Cassone A; Romagnani S; Maggi E
    J Infect Dis; 2002 Jul; 186(1):87-93. PubMed ID: 12089666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune cell-mediated protection against vaginal candidiasis: evidence for a major role of vaginal CD4(+) T cells and possible participation of other local lymphocyte effectors.
    Santoni G; Boccanera M; Adriani D; Lucciarini R; Amantini C; Morrone S; Cassone A; De Bernardis F
    Infect Immun; 2002 Sep; 70(9):4791-7. PubMed ID: 12183521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis.
    De Bernardis F; Liu H; O'Mahony R; La Valle R; Bartollino S; Sandini S; Grant S; Brewis N; Tomlinson I; Basset RC; Holton J; Roitt IM; Cassone A
    J Infect Dis; 2007 Jan; 195(1):149-57. PubMed ID: 17152019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans.
    de Bernardis F; Santoni G; Boccanera M; Spreghini E; Adriani D; Morelli L; Cassone A
    Infect Immun; 2000 Jun; 68(6):3297-304. PubMed ID: 10816477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.
    Polonelli L; De Bernardis F; Conti S; Boccanera M; Gerloni M; Morace G; Magliani W; Chezzi C; Cassone A
    J Immunol; 1994 Mar; 152(6):3175-82. PubMed ID: 8144911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
    Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
    Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique.
    Pietrella D; Rachini A; Torosantucci A; Chiani P; Brown AJ; Bistoni F; Costantino P; Mosci P; d'Enfert C; Rappuoli R; Cassone A; Vecchiarelli A
    Vaccine; 2010 Feb; 28(7):1717-25. PubMed ID: 20038431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis.
    De Bernardis F; Boccanera M; Adriani D; Girolamo A; Cassone A
    Infect Immun; 2002 May; 70(5):2725-9. PubMed ID: 11953420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida-specific antibodies during experimental vaginal candidiasis in mice.
    Wozniak KL; Wormley FL; Fidel PL
    Infect Immun; 2002 Oct; 70(10):5790-9. PubMed ID: 12228309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human natural yeast killer toxin-like candidacidal antibodies.
    Polonelli L; De Bernadis F; Conti S; Boccanera M; Magliani W; Gerloni M; Cantelli C; Cassone A
    J Immunol; 1996 Mar; 156(5):1880-5. PubMed ID: 8596040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model.
    Chami F; Chami N; Bennis S; Trouillas J; Remmal A
    J Antimicrob Chemother; 2004 Nov; 54(5):909-14. PubMed ID: 15456732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis.
    Vultaggio A; Lombardelli L; Giudizi MG; Biagiotti R; Mazzinghi B; Scaletti C; Mazzetti M; Livi C; Leoncini F; Romagnani S; Maggi E; Piccinni MP
    Microbes Infect; 2008 Feb; 10(2):166-74. PubMed ID: 18249024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquiritigenin, a licorice flavonoid, helps mice resist disseminated candidiasis due to Candida albicans by Th1 immune response, whereas liquiritin, its glycoside form, does not.
    Lee JY; Lee JH; Park JH; Kim SY; Choi JY; Lee SH; Kim YS; Kang SS; Jang EC; Han Y
    Int Immunopharmacol; 2009 May; 9(5):632-8. PubMed ID: 19264152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the oestrogen-dependent vaginal candidosis murine model in evaluating the efficacy of various therapies against vaginal Candida albicans infection.
    Hamad M; Muta'eb E; Abu-Shaqra Q; Fraij A; Abu-Elteen K; Yasin SR
    Mycoses; 2006 Mar; 49(2):104-8. PubMed ID: 16466442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mildly oxidized low-density lipoprotein inhibits the in vitro induction of the specific antibody response to Candida albicans.
    Giordani L; Mattioli B; Quaranta MG; Giacomini E; Libri I; Varì R; Masella R; Viora M
    Free Radic Biol Med; 2005 Oct; 39(7):960-9. PubMed ID: 16140215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mannoprotein constituent of Candida albicans cooperates with antigen in the induction of a specific primary antibody response in cultures of human lymphocytes.
    Luzzati AL; Giacomini E; Torosantucci A; Giordani L; Cassone A
    J Biol Regul Homeost Agents; 1990; 4(4):142-9. PubMed ID: 2096599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.